Alnylam Pharmaceuticals is managing an extensive capital expansion program. The portfolio includes several hundred capital projects, with scope ranging from infrastructure expansions through the continued growth of research and manufacturing programs.
PMA has been tasked with establishing a Project Controls Department to support this ongoing capital program. The initial deliverable was the development of a project cost planning, management, and forecasting tool that supports the Project Management efforts. The tool provides detailed project cost reporting as well as portfolio analysis, highlighting upcoming work, and variance analysis. Additional services include project scheduling support and change management control.